Stronger involvement of patients in the reporting on side effects is an integral part of Europe's pharmacovigilance system and – once in place - the new symbol will contribute to strengthen what is already one of the most advanced systems in the world."
Patsientide ulatuslikum kaasamine ravimi kõrvalmõjudest teatamisse on Euroopa ravimiohutuse järelevalvesüsteemi lahutamatu osa.